Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 12, 2011Neurology

Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab

View Full Paper
Ask AI
Bookmark
Share

Authors

HPHannah PellkoferMKMarkus KrumbholzABAchim Berthele

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Pellkofer et al. (2011) studied this question.

synapsesocial.com/papers/69dcdf2a854f360ad63594bfhttps://doi.org/10.1212/wnl.0b013e3182152881
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Highly sensitive B cell analysis predicts response to rituximab therapy in rheumatoid arthritis2008 · 216 citations
  2. 2Effect of Rituximab on the Peripheral Blood and Cerebrospinal Fluid B Cells in Patients With Primary Progressive Multiple Sclerosis2005 · 212 citations
  3. 3The clinical course of neuromyelitis optica (Devic’s syndrome)1999 · 1,830 citations
  4. 4Response to B-cell–depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura2007 · 300 citations
  5. 5Rituximab: Expanding Role in Therapy for Lymphomas and Autoimmune Diseases2004 · 215 citations